Table 2. Prophylactic treatment of each mucosal defect group.
Prophylactic treatment | |||||||
No treatment | Steroid injection | Steroid injection followed by oral steroid | |||||
Group A (n = 45) | 18 | (40 %) | 22 | (49 %) | 5 | (11 %) | |
Group B (n = 45) | 10 | (22 %) | 25 | (56 %) | 10 | (22 %) | |
Group C (n = 25) | 5 | (20 %) | 6 | (24 %) | 14 | (56 %) | |
Total (n = 115) | 33 | (29 %) | 53 | (46 %) | 29 | (25 %) |
Patients were categorized by size of lesion in reference to the esophageal lumen into Group A (> 3/4 and < 7/8), Group B (> 7/8 and less than the entire circumference), and Group C (the entire circumference). Treatment type was determined by the time period.